These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 24590624
1. Methyl-beta-cyclodextrins: the role of number and types of substituents in solubilizing power. Fenyvesi É, Szemán J, Csabai K, Malanga M, Szente L. J Pharm Sci; 2014 May; 103(5):1443-52. PubMed ID: 24590624 [Abstract] [Full Text] [Related]
2. Evaluation of the cytotoxicity of beta-cyclodextrin derivatives: evidence for the role of cholesterol extraction. Kiss T, Fenyvesi F, Bácskay I, Váradi J, Fenyvesi E, Iványi R, Szente L, Tósaki A, Vecsernyés M. Eur J Pharm Sci; 2010 Jul 11; 40(4):376-80. PubMed ID: 20434542 [Abstract] [Full Text] [Related]
3. Methylated β-cyclodextrins: influence of degree and pattern of substitution on the thermodynamics of complexation with tauro- and glyco-conjugated bile salts. Schönbeck C, Westh P, Madsen JC, Larsen KL, Städe LW, Holm R. Langmuir; 2011 May 17; 27(10):5832-41. PubMed ID: 21510679 [Abstract] [Full Text] [Related]
4. Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroids. Zia V, Rajewski RA, Bornancini ER, Luna EA, Stella VJ. J Pharm Sci; 1997 Feb 17; 86(2):220-4. PubMed ID: 9040099 [Abstract] [Full Text] [Related]
5. Characterization of a new methylated Beta-cyclodextrin with a low degree of substitution by electrospray ionization mass spectrometry and liquid chromatography/mass spectrometry. Jacquet R, Elfakir C, Lafosse M. Rapid Commun Mass Spectrom; 2005 Feb 17; 19(21):3097-102. PubMed ID: 16200651 [Abstract] [Full Text] [Related]
6. Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery. Nogueiras-Nieto L, Sobarzo-Sánchez E, Gómez-Amoza JL, Otero-Espinar FJ. Eur J Pharm Biopharm; 2012 Apr 17; 80(3):585-95. PubMed ID: 22182528 [Abstract] [Full Text] [Related]
7. Novel behavior of O-methylated beta-cyclodextrins in inclusion of meso-tetraarylporphyrins. Kano K, Nishiyabu R, Doi R. J Org Chem; 2005 Apr 29; 70(9):3667-73. PubMed ID: 15845005 [Abstract] [Full Text] [Related]
8. Spectroscopic studies and molecular modeling for understanding the interactions between cholesterol and cyclodextrins. Castagne D, Dive G, Evrard B, Frédérich M, Piel G. J Pharm Pharm Sci; 2010 Apr 29; 13(3):362-77. PubMed ID: 21092709 [Abstract] [Full Text] [Related]
9. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM, Elkheshen SA, Ghorab MM. Eur J Pharm Biopharm; 2008 Nov 29; 70(3):819-27. PubMed ID: 18655829 [Abstract] [Full Text] [Related]
10. The use of captisol (SBE7-β-CD) in oral solubility-enabling formulations: Comparison to HPβCD and the solubility-permeability interplay. Beig A, Agbaria R, Dahan A. Eur J Pharm Sci; 2015 Sep 18; 77():73-8. PubMed ID: 26006306 [Abstract] [Full Text] [Related]
11. Environmental significance of the diclofop-methyl and cyclodextrin inclusion complexes. Cai X, Zhang A, Liu W. J Environ Sci Health B; 2006 Sep 18; 41(7):1115-29. PubMed ID: 16923595 [Abstract] [Full Text] [Related]
12. Use of cyclodextrins as solubilizing agents for simvastatin: effect of hydroxypropyl-β-cyclodextrin on lactone/hydroxyacid aqueous equilibrium. Ungaro F, Giovino C, Catanzano O, Miro A, Mele A, Quaglia F, La Rotonda MI. Int J Pharm; 2011 Feb 14; 404(1-2):49-56. PubMed ID: 21056648 [Abstract] [Full Text] [Related]
13. The unexpected increase of clotrimazole apparent solubility using randomly methylated β-cyclodextrin. Pradines B, Gallard JF, Iorga BI, Gueutin C, Ponchel G, Loiseau PM, Bouchemal K. J Mol Recognit; 2015 Feb 14; 28(2):96-102. PubMed ID: 25604751 [Abstract] [Full Text] [Related]
14. Characterization of aspartame-cyclodextrin complexation. Sohajda T, Béni S, Varga E, Iványi R, Rácz A, Szente L, Noszál B. J Pharm Biomed Anal; 2009 Dec 05; 50(5):737-45. PubMed ID: 19586735 [Abstract] [Full Text] [Related]
15. Use of cyclodextrins as a cosmetic delivery system for fragrance materials: linalool and benzyl acetate. Numanoğlu U, Sen T, Tarimci N, Kartal M, Koo OM, Onyüksel H. AAPS PharmSciTech; 2007 Oct 19; 8(4):E85. PubMed ID: 18181546 [Abstract] [Full Text] [Related]
16. Aggregation of cyclodextrins as an important factor to determine their complexation behavior. Bikádi Z, Kurdi R, Balogh S, Szemán J, Hazai E. Chem Biodivers; 2006 Nov 19; 3(11):1266-78. PubMed ID: 17193241 [Abstract] [Full Text] [Related]
17. Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin. Grillo R, de Melo NF, Moraes CM, de Lima R, Menezes CM, Ferreira EI, Rosa AH, Fraceto LF. J Pharm Biomed Anal; 2008 Jun 09; 47(2):295-302. PubMed ID: 18289821 [Abstract] [Full Text] [Related]
18. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation. Chi L, Liu R, Guo T, Wang M, Liao Z, Wu L, Li H, Wu D, Zhang J. Int J Pharm; 2015 Feb 20; 479(2):349-56. PubMed ID: 25575474 [Abstract] [Full Text] [Related]
19. Cytotoxicity of different types of methylated beta-cyclodextrins and ionic derivatives. Kiss T, Fenyvesi F, Pasztor N, Feher P, Varadi J, Kocsan R, Szente L, Fenyvesi E, Szabo G, Vecsernyes M, Bacskay I. Pharmazie; 2007 Jul 20; 62(7):557-8. PubMed ID: 17718201 [Abstract] [Full Text] [Related]
20. Isothermal titration calorimetry and 1H NMR studies on host-guest interaction of paeonol and two of its isomers with beta-cyclodextrin. Sun DZ, Li L, Qiu XM, Liu F, Yin BL. Int J Pharm; 2006 Jun 19; 316(1-2):7-13. PubMed ID: 16554127 [Abstract] [Full Text] [Related] Page: [Next] [New Search]